Multicenter retrospective study reveals skeletal and dental issues in adults with X-linked hypophosphatemia, suggesting significant health impacts.
the burden of XLH disease in adulthood is determined by skeletal manifestations and dental disease and may be more severe in males. Additionally, cardiometabolic impairment may not be common. The disease burden impacts most of individuals, beyond those presenting the criteria for burosumab reimbursement.
No takes yet. Share an insight, caveat, or question.
Carrara et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: